Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

BIO-TECHNE (TECH) Short-Term Debt repayments: 2014-2025

Historic Short-Term Debt repayments for BIO-TECHNE (TECH) over the last 10 years, with Sep 2025 value amounting to $46.0 million.

  • BIO-TECHNE's Short-Term Debt repayments rose 142.11% to $46.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $123.0 million, marking a year-over-year decrease of 40.00%. This contributed to the annual value of $77.0 million for FY2025, which is 69.92% down from last year.
  • As of Q3 2025, BIO-TECHNE's Short-Term Debt repayments stood at $46.0 million, which was down 8.00% from $50.0 million recorded in Q2 2025.
  • Over the past 5 years, BIO-TECHNE's Short-Term Debt repayments peaked at $441.0 million during Q3 2022, and registered a low of $3.1 million during Q2 2022.
  • Its 3-year average for Short-Term Debt repayments is $44.3 million, with a median of $50.0 million in 2025.
  • Examining YoY changes over the last 5 years, BIO-TECHNE's Short-Term Debt repayments showed a top increase of 762.59% in 2022 and a maximum decrease of 97.60% in 2022.
  • Quarterly analysis of 5 years shows BIO-TECHNE's Short-Term Debt repayments stood at $58.1 million in 2021, then grew by 11.24% to $64.7 million in 2022, then declined by 10.30% to $58.0 million in 2023, then slumped by 72.86% to $19.0 million in 2024, then spiked by 142.11% to $46.0 million in 2025.
  • Its last three reported values are $46.0 million in Q3 2025, $50.0 million for Q2 2025, and $8.0 million during Q1 2025.